首页> 外文期刊>International Journal of Biochemistry, Biophysics & Molecular Biology >'First Detection of PER-Type Extended-Spectrum β-lactamases at Saint Camille Hospital Center of Ouagadougou, Burkina Faso '
【24h】

'First Detection of PER-Type Extended-Spectrum β-lactamases at Saint Camille Hospital Center of Ouagadougou, Burkina Faso '

机译:“在布基纳法索瓦加杜古圣卡米尔医院中心首次检测到PER型超广谱β-内酰胺酶”

获取原文
       

摘要

Resistance to a wide variety of common antimicrobials is observed among clinical strains designated as extended-spectrum β-lactamase (ESBL) producers. They produce enzymatic proteins that effectively inactivate cephalosporins and aztreonam and are a serious global health problem that complicates treatment strategies. Many studies report a high prevalence of ESBL producers among Gram-negative bacilli. The purpose of this work was to identify of PER resistance gene in enterobacterial strains. Gram-negative bacilli resistant to at least one third-generation cephalosporin, Aztreonam or showing a synergistic image between amoxicillin + clavulanic acid and a third generation cephalosporin were isolated during an antibiogram. Antibiotic resistance was detected for the following antibiotics: Ceftriaxone, Cefotaxime, Ceftazidime and Aztreonam. A classical polymerase chain reaction (PCR) analysis of the β-lactamase PER (Pseudomonas Extended Resistance) gene was performed using specific primers in 60 ESBL-producing isolates. Among 250 strains of Gram negative bacilli collected, 60 strains (24%) showed resistance to antibiotics used. Stool samples are a major source of ESBL producers. The highest prevalence of resistant strains was observed in Escherichia coli with a rate of 35%. Among the producers of ESBL isolates, the presence of the PER gene was detected in the present study by up to 15% in 6 bacterial species. This study represents the first detection of the PER gene in Burkina Faso.
机译:在指定为广谱β-内酰胺酶(ESBL)生产者的临床菌株中观察到了对多种常见抗菌素的耐药性。它们产生可有效灭活头孢菌素和氨曲南的酶蛋白,是严重的全球性健康问题,使治疗策略复杂化。许多研究报告ESBL生产者在革兰氏阴性杆菌中普遍存在。这项工作的目的是确定肠杆菌菌株中的PER抗性基因。在抗菌素谱图中分离出对至少一种第三代头孢菌素,氨曲南具有抗性或显示阿莫西林+克拉​​维酸和第三代头孢菌素之间具有协同作用的图像的革兰氏阴性杆菌。检测到以下抗生素的抗生素耐药性:头孢曲松,头孢噻肟,头孢他啶和氨曲南。使用特异性引物在60个产生ESBL的分离物中进行β-内酰胺酶PER(假单胞菌延伸抗性)基因的经典聚合酶链反应(PCR)分析。在收集的250株革兰氏阴性菌中,有60株(占24%)显示出对所用抗生素的抗性。粪便样本是ESBL生产商的主要来源。在大肠杆菌中观察到耐药菌株的最高流行率,为35%。在ESBL分离物的生产者中,在本研究中检测到PER基因的存在,在6种细菌中最多检测到15%。这项研究代表了在布基纳法索首次检测到PER基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号